DURHAM, N.C.–(BUSINESS WIRE)–December 9, 2020 — Mycovia Pharmaceuticals, Inc. (“Mycovia”),
Chemotherapy and blinatumomab improves survival for patients with B-cell acute lymphoblastic leukemia
A study led by The University of Texas MD Anderson
Artificial intelligence technology helps Parkinson’s patients during COVID-19 pandemic
The COVID-19 pandemic is leading a Purdue University innovator to
Close to 17 percent of patients recovered from COVID-19 could still carry virus
A new study in the American Journal of Preventive Medicine
Study reveals kidney disease or injury is associated with much higher risk of mortality for COVID-19 patients in ICU
New research published in Anaesthesia (a journal of the Association
Anti-Influenza Drug Avigan® Tablet Meets Primary Endpoint in Phase III Clinical Trial in Japan for COVID-19 Patients
TOKYO — September 23, 2020 FUJIFILM Toyama Chemical Co., Ltd.
Study highlights need for genetic testing for Kentucky patients with lung cancer
A study led by researchers at the University of Kentucky
Drug May Reduce Need for Ventilators in COVID-19 Patients
FRIDAY, Sept. 18, 2020 — An inflammation-fighting medicine was associated
Asthma patients given risky levels of steroid tablets
More than one quarter of asthma patients have been prescribed
Protein drug 'reversed' deadly cytokine storm in COVID-19 patients
Could THIS stop coronavirus in its tracks? Protein drug boosts